In the most closely-watched death penalty case in years, the U.S. Supreme Court on Monday ruled 5-4(pdf) that Oklahoma can use the controversial and experimental execution drug midazolam that was behind the last year’s horrific killing of 38-year-old man Clayton Lockett—who writhed and groaned for 43 minutes before ultimately succumbing to a heart attack. The decision not only gives the approval for states …